BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4860981)

  • 1. Effects of two butyrophenone compounds on acute schizophrenic patients: speculation on the neurophysiologic sites of action.
    Gallant DM; Bishop M; Guerrero-Figueroa R
    Int J Neuropsychiatry; 1967 Aug; 3():Suppl 1:53-60. PubMed ID: 4860981
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of trifluperidol in chronic schizaphrenia.
    Clark ML; Huber WK; Kyriakopoulos AA; Ray TS; Colmore JP; Ramsey HR
    Psychopharmacologia; 1968; 12(3):193-203. PubMed ID: 4917285
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of the schizophrenic patient in a community psychiatric practice.
    Tobin JM
    Dis Nerv Syst; 1968 May; 29(5):Suppl:27-34. PubMed ID: 4876987
    [No Abstract]   [Full Text] [Related]  

  • 4. Pilot clinical study with trifluperidol (Trisedyl) therapy in psychotic patients.
    Dolezalová V; Faltus F; Soucek K
    Act Nerv Super (Praha); 1974 Aug; 16(3):171. PubMed ID: 4609154
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of trifluperidol, trifluoperazine and chlorpromazine in preschool schizophrenic children: the value of less sedative antipsychotic agents.
    Fish B; Campbell M; Shapiro T; Floyd A
    Curr Ther Res Clin Exp; 1969 Oct; 11(10):589-95. PubMed ID: 4981301
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of chronic schizophrenic patients with haloperidol and chlorpromazine combined.
    Jones B; Lehmann HE; Saxena BM; Ban TA
    Curr Ther Res Clin Exp; 1968 Jun; 10(6):276-8. PubMed ID: 4969832
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical efficacy of haloperidol in chronic psychotic patients.
    Lapolla A
    Int J Neuropsychiatry; 1967 Aug; 3():Suppl l:68-77. PubMed ID: 6051725
    [No Abstract]   [Full Text] [Related]  

  • 8. CI-601, a butyrophenone derivative, in the treatment of chronically withdrawn schizophrenic patients.
    Villeneuve C; Ananth JV; Ban TA; Lehmann HE
    Curr Ther Res Clin Exp; 1970 Apr; 12(4):223-9. PubMed ID: 4985943
    [No Abstract]   [Full Text] [Related]  

  • 9. BL-KR140: a controlled evaluation in chronic schizophrenic patients previously stabilized on chlorpromazine.
    Gallant DM; Bishop MP; O'Meallie L
    Curr Ther Res Clin Exp; 1967 Aug; 9(8):447-50. PubMed ID: 4962470
    [No Abstract]   [Full Text] [Related]  

  • 10. Haloperidol and trifluperidol in psychiatry.
    Drug Ther Bull; 1968 Jul; 6(15):58-9. PubMed ID: 5691291
    [No Abstract]   [Full Text] [Related]  

  • 11. [Radioprotective properties of butyrophenone derivatives].
    Uray Z; Farcasanu M; Maniu M
    Agressologie; 1970; 11(4):357-60. PubMed ID: 5485665
    [No Abstract]   [Full Text] [Related]  

  • 12. Trifluperidol and trifluoperazine in acute schizophrenic patients.
    Sugerman AA; Williams BH
    J New Drugs; 1965; 5(5):318-26. PubMed ID: 5329635
    [No Abstract]   [Full Text] [Related]  

  • 13. [A year's use of R2498 with chronic ambulatory schizophrenic patients].
    Madalena JC
    Hospital (Rio J); 1965 Aug; 68(2):279-84. PubMed ID: 5295121
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison of triperidol with perphenazine in schizophrenic psychoses. Effect on the photomyoclonic threshold].
    Náhunek K; Hádlík J; Rodová A; Misurec J; Vanýsek J
    Act Nerv Super (Praha); 1970 Jan; 12(1):56-7. PubMed ID: 4907390
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical results with trifluoperidol in schizophrenic patients].
    Navarro MP; Assis LM; Martins C
    Rev Assoc Med Bras; 1966 Dec; 12(12):497-501. PubMed ID: 5241539
    [No Abstract]   [Full Text] [Related]  

  • 16. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
    Reschke RW
    Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of schizophrenic patients with triperidol (trisedil)].
    Ezhkov AA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(9):1394-400. PubMed ID: 5705722
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of trifluperidol in chronic schizophrenia.
    Clark ML; Huber WK; Kyriakopoulos AA; Ray TS; Colmore JP; Ramsey HR
    Psychopharmacologia; 1968; 12(3):193-203. PubMed ID: 4916807
    [No Abstract]   [Full Text] [Related]  

  • 19. A double-blind comparison of trifluperidol and trifluoperazine in acute schizophrenic patients.
    Schiele BC; Janecek J; Zimmermann R
    Compr Psychiatry; 1969 Sep; 10(5):355-60. PubMed ID: 4389944
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative study of trifluperidol and trifluoperazine in the treatment of acute schizophrenia].
    Gauthier R; Hillel J; Bordeleau JM; Tétreault L
    Union Med Can; 1967 Aug; 96(8):936-43. PubMed ID: 5618135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.